Snapshot · Russell 3000 · generated 2026-10-15 21:34 UTC

BMY — Bristol-Myers Squibb Company

UNDERVALUED (MOS +60.8%) · Quality 74/100

BMY - Bristol-Myers Squibb Company
Data generated 2026-10-15 21:34 UTC (nightly scan, universe: Russell 3000).
Price: 60.57 USD
Intrinsic value: 154.48 USD
Margin of safety: +60.8%
Implied growth (reverse DCF): -6.6% (model assumes +6.5%)
Valuation: UNDERVALUED
Value Score: 60.1
Quality: 74/100
Moat score: 47.2 (erosion: none)
UNDERVALUED (MOS +60.8%) - Quality 74/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/BMY
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

60.57

Intrinsic value

154.48

Margin of safety

+60.8%

Implied growth (reverse DCF)

-6.6%

model assumes +6.5%

Value Score

60.1

Quality

Psychology

8.5

Discovery

124.9

price/volume attention only

Moat score

47.2

erosion: none

Value Score: top 3% of Russell 3000 · Quality: top 22%

Dividend: 2.52/share (TTM) · yield 4.2% · payout 56%

Open the interactive Deep Dive for BMY →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/BMY - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is BMY undervalued?

As of 2026-10-15, BMY trades at 60.57 against a computed intrinsic value of 154.48 (+60.8% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Bristol-Myers Squibb Company's Value Score?

Bristol-Myers Squibb Company's Value Score is 60.1 as of 2026-10-15 - it combines value, quality, crowd psychology and market attention into one number.

Does BMY pay a dividend?

Yes - BMY's trailing twelve-month dividend is 2.52/share, a yield of 4.2% at the current price (as of 2026-10-15).